Vous êtes ici

Lexaria Bioscience Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Diversified Industries
Symbole: 
LXX
Indice CSE: 
Devise: 

Lexaria is a food sciences company focused on the beneficial properties of cannabinoids and other molecules. In 2015 Lexaria introduced eleven new consumer food products all utilizing the benefits of its patent pending hemp oil infusion technology: Coffee, Hot Chocolate, 7 flavours of Tea, and 2 flavours of Protein Energy Bars. Lexaria has filed for patent protection in the US and Internationally for a unique delivery method of cannabinoids, vitamins, nicotine and non-steriodal anti-inflammatories (NSAIDs).

Vous êtes ici

Lexaria Bioscience Corp. (LXX)

SEDAR Information

Information d'entreprise

Addresse
950 - 1130 West Pender Street
Vancouver, BC V6E 4A4
Canada
Téléphone
250-765-6424
Fax
1-604-685-7602
Courriel
cbunka@lexariaenergy.com
URL
http://www.lexariaenergy.com
Date d’inscription à la cote
Mercredi, octobre 28, 2009
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
Chris Bunka
Vérificateur
Davidson & Company LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
3,001,476
Réservé à l'émission: 
10,285,820

Company Officers

Chris Bunka, CEO
John Docherty, President
Allan Spissinger CPA, CA, CFO

Communiqués de presse

Bulletins

11/01/2021

2021-0112 –Consolidation - Lexaria Bioscience Corp. (LXX)

Le 11 janvier/January 2021

Lexaria Bioscience Corp. has announced a consolidation of its issued and outstanding common shares. At the rate of one (1) new share for each thirty (30) shares held.

The consolidation will be effected at 4:30 p.m. (EST) on January 11, 2021 with the shares trading on a post-consolidated basis on January 12, 2021.

Upon completion of the split, there will be approximately 3,001,476 shares issued and outstanding.

Advertisement

Publicité

Latest CSE News

Évènements à venir